AtriCure Valuation
| ATRC Stock | USD 38.41 0.10 0.26% |
At this time, the firm appears to be overvalued. AtriCure shows a prevailing Real Value of $31.65 per share. The current price of the firm is $38.41. Our model approximates the value of AtriCure from analyzing the firm fundamentals such as Return On Equity of -0.0611, profit margin of (0.06) %, and Current Valuation of 1.87 B as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that AtriCure's price fluctuation is not too volatile at this time. Calculation of the real value of AtriCure is based on 3 months time horizon. Increasing AtriCure's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since AtriCure is currently traded on the exchange, buyers and sellers on that exchange determine the market value of AtriCure Stock. However, AtriCure's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 38.41 | Real 31.65 | Hype 38.41 | Naive 39.04 |
The real value of AtriCure Stock, also known as its intrinsic value, is the underlying worth of AtriCure Company, which is reflected in its stock price. It is based on AtriCure's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of AtriCure's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of AtriCure helps investors to forecast how AtriCure stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AtriCure more accurately as focusing exclusively on AtriCure's fundamentals will not take into account other important factors: About AtriCure Valuation
The stock valuation mechanism determines AtriCure's current worth on a weekly basis. Our valuation model uses a comparative analysis of AtriCure. We calculate exposure to AtriCure's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of AtriCure's related companies.AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company was incorporated in 2000 and is headquartered in Mason, Ohio. Atricure operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 875 people.
Complementary Tools for AtriCure Stock analysis
When running AtriCure's price analysis, check to measure AtriCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AtriCure is operating at the current time. Most of AtriCure's value examination focuses on studying past and present price action to predict the probability of AtriCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AtriCure's price. Additionally, you may evaluate how the addition of AtriCure to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |